Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
NCT ID: NCT05397600
Last Updated: 2024-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
684 participants
INTERVENTIONAL
2022-06-22
2024-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients
NCT03825380
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01298700
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
NCT01099774
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
NCT05401357
Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT01568008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T4032
Bimatoprost Ophthalmic
Eyedrops
Lumigan
Bimatoprost Ophthalmic
Eyedrops
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bimatoprost Ophthalmic
Eyedrops
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both eyes diagnosed open-angle glaucoma or ocular hypertension
Exclusion Criteria
* Known or suspected hypersensitivity to one of the components of the Investigational Medicinal Product(s)
* Pregnancy or breast-feeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoires Thea
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Eye Center - Chandler
Chandler, Arizona, United States
Eye Physicians & Surgeons of Arizona - Glendale Office
Glendale, Arizona, United States
Arizona Glaucoma Specialists - Phoenix
Phoenix, Arizona, United States
Walman Eye Center - Sun City
Sun City, Arizona, United States
Velvet Clinical Research
Burbank, California, United States
Specialty Eye Care Medical Center - Glendale
Glendale, California, United States
Global Research Management, Inc.
Glendale, California, United States
Inland Eye Specialists - Hemet
Hemet, California, United States
Diabetic Eye Medical Clinic - Inglewood
Inglewood, California, United States
Lakeside Vision Center - Irvine
Irvine, California, United States
Sage Eyecare
Los Angeles, California, United States
Global Vision Eye Care - Los Angeles- Rock Central
Los Angeles, California, United States
North Valley Eye Medical Group, Inc.
Mission Hills, California, United States
California Eye Specialists Medical Group Inc. - Monrovia
Monrovia, California, United States
Aesthetic Eye Care Institute - Eye Research Foundation
Newport Beach, California, United States
Foothill Eye Institute - Pasadena
Pasadena, California, United States
North Bay Eye Associates - Petaluma - 104 Lynch Creek Way
Petaluma, California, United States
California Eye Specialists Medical Group Inc. - Redlands
Redlands, California, United States
OC Surgical Eye Institute
Santa Ana, California, United States
Santa Barbara Eyecare - Santa Barbara
Santa Barbara, California, United States
Wolstan & Goldberg Eye Associates
Torrance, California, United States
ICON Eye Care - Grand Junction
Grand Junction, Colorado, United States
Nature Coast Clinical Research - Crystal River
Crystal River, Florida, United States
East Coast Institute for Research - Jacksonville
Jacksonville, Florida, United States
Ocala Eye - 3130 Location
Ocala, Florida, United States
Bascom Palmer Eye Institute - University of Miami Health System - Palm Beach Gardens
Palm Beach Gardens, Florida, United States
East Florida Eye Institute
Stuart, Florida, United States
Coastal Research Associates, LLC. - Atlanta
Roswell, Georgia, United States
Coastal Research Associates, LLC. - Atlanta
Roswell, Georgia, United States
Indiana University School of Medicine - Eugene and Marilyn Glick Eye Institute
Indianapolis, Indiana, United States
Fraser Eye Care Center - Fraser
Fraser, Michigan, United States
Great Lakes Eye Care - St. Joseph
Saint Joseph, Michigan, United States
Huron Ophthalmology, P.C.
Ypsilanti, Michigan, United States
Comprehensive Eye Care, Ltd.
Washington, Missouri, United States
NV Eye Surgery - Henderson
Henderson, Nevada, United States
Rochester Ophthalmological Group, PC - Brighton
Rochester, New York, United States
"Clinic-LJ" Ltd
Winston-Salem, North Carolina, United States
Cincinnati Eye Institute - Blue Ash
Cincinnati, Ohio, United States
Abrams Eye Center, Inc.
Cleveland, Ohio, United States
AMA Eye Research Institute
Marysville, Ohio, United States
Legacy Pulmonary Medical Group - Good Samaritan Medical Center
Portland, Oregon, United States
Scott & White Cancer Center - Killeen
Cranberry Township, Pennsylvania, United States
Scheie Eye Institute - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Wills Eye Hospital
Philadelphia, Pennsylvania, United States
Advancing Vision Research - Goodlettsville
Goodlettsville, Tennessee, United States
Total Eye Care, P.A.
Memphis, Tennessee, United States
Vanderbilt University Medical Center - Vanderbilt Eye Institute - Main Campus
Nashville, Tennessee, United States
Texan Eye - Austin - Main Central
Austin, Texas, United States
Southwest Eye Institute
El Paso, Texas, United States
Houston Eye Associates - North Loop
Houston, Texas, United States
Houston Eye Associates (HEA) - Gramercy Location
Houston, Texas, United States
San Antonio Eye Center, P.A. - McCullough Ave
San Antonio, Texas, United States
Rashid, Rice, Flynn & Reilly Eye Associates - San Antonio Clinic
San Antonio, Texas, United States
St. George Eye Center - St. George
St. George, Utah, United States
Piedmont Eye Center - Lynchburg
Lynchburg, Virginia, United States
Specialty Eye Care Center - Bellevue
Bellevue, Washington, United States
Prism Eye Institute - Oakville
Oakville, Ontario, Canada
Clinique Bellevue - Laval
Laval, Quebec, Canada
Clínica Oftalmológica del Caribe
Barranquilla, , Colombia
Fundación Oftalmológica Nacional (FUNDONAL)
Bogotá, , Colombia
Clinica de Oftalmologia de Cali SA
Cali, , Colombia
Fundación Oftalmológica de Santander FOSCAL
Floridablanca, , Colombia
Clinica de Oftalmologia Sandiego
Medellín, , Colombia
Instituto Nacional de Investigacion en Oftalmologia
Medellín, , Colombia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LT4032-302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.